|
Dzhugashvili M, Luengo-Gil G, García T, González-Conejero R, Conesa-Zamora P, Escolar PP, Calvo F, Vicente V, Ayala de la Peña F. Role of genetic polymorphisms in NFKB-mediated inflammatory pathways in response to primary chemoradiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):595-602. doi: 10.1016/j.ijrobp.2014.06.060. PubMed PMID: 25304949.
AÑO: 2014; IF: 5.859
|
25304949
|
Vicente Conesa MA, Garcia-Martinez E, Gonzalez Billalabeitia E, Chaves Benito A, Garcia Garcia T, Vicente Garcia V, Ayala de la Peña F. Predictive value of peripheral blood lymphocyte count in breast cancer patients treated with primary chemotherapy. Breast. 2012 Aug;21(4):468-74. doi: 10.1016/j.breast.2011.11.002. Epub 2011 Nov 26. PubMed PMID: 22119767.
AÑO: 2012; IF: 1.967
|
|
Sastre J, Aranda E, Massutí B, Tabernero J, Chaves M, Abad A, Carrato A, Reina JJ, Queralt B, Gómez-España A, González-Flores E, Rivera F, Losa F, García T, Sanchez-Rovira P, Maestu I, Díaz-Rubio E. Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: comparative outcomes from the 03-TTD-01 phase III study. Crit Rev Oncol Hematol. 2009 May;70(2):134-44. doi: 10.1016/j.critrevonc.2008.11.002. Epub 2008 Dec 25. PubMed PMID: 19111473.
AÑO: 2009; IF: 5.269
|
|
Zafra M, Ayala F, Gonzalez-Billalabeitia E, Vicente E, Gonzalez-Cabezas P, García T, Macías JA, Vicente V. Impact of whole-body 18F-FDG PET on diagnostic and therapeutic management of Medical Oncology patients. Eur J Cancer. 2008 Aug;44(12):1678-83. doi: 10.1016/j.ejca.2008.05.021. Epub 2008 Jul 7. PubMed PMID: 18614352.
AÑO: 2008; IF: 4.475
|